IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination

Influenza viruses continue to cause a substantial global disease burden. Despite influenza vaccination, some individuals succumb to life-threatening influenza or death. Yet our understanding of immune features elicited by vaccination and influenza A and B virus (IAV, IBV) infection is limited. To define molecular signatures of influenza-specific B-cells, we performed scRNA-sequencing of influenza-specific B-cells in vaccinees and hospitalized IAV/IBV-infected patients using HA-probes. We observed increased interferon-stimulated gene signatures (IF44L, IFITM1 and XAF1), in total B-cells from IBV-patients, but not at 1-month following patients' recovery or in IAV-patients or vaccinees. Phenotypic differentiation and isotype class-switching of HA-specific B-cells were observed following vaccination, with clonal sharing between memory and atypical B-cell phenotypes. In-vitro influenza virus infection experiments showed IBVs having higher infectivity of human PBMCs, including B-cells, and reduced B-cell proliferation compared to IAV, potentially associated with antiproliferative effect of IFITM1. We provide key insights into B-cell immunity towards IBV and IAV infections and vaccination, which will inform rational vaccine design and therapeutic strategies aimed at eliciting robust HA-specific B-cell responses, while minimizing adverse effects caused by natural infection.

Authors

Institutions

Publication Details

Journal
EMBO Molecular Medicine
Published
2026-03-09
DOI
https://doi.org/10.1038/s44321-026-00395-8
Citations
1
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
31.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination

Paul Glyndwr Thomas, Jennifer R. Habel, Steven Rockman, Ilariya Tarasova et al.
1 citations
EMBO Molecular Medicine
Influenza Virus Research Studies
31.52
article

IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination

Paul Glyndwr Thomas, Jennifer R. Habel, Steven Rockman, Ilariya Tarasova, S.B.H. Kent, Allen Cheng, Rubaiyea Farrukee, Jason A. Trubiano, Hayley A. McQuilten, Sarah L. Londrigan, Wuji Zhang, Brad Gilbertson, Jan Schroeder, Shihan Li, Lukasz Kedzierski, Tom Kotsimbos, LJ Allen, Jeremy Chase Crawford, E Kaitlynn Allen, Katherine Kedzierska, Adam K Wheatley, Thi H O Nguyen
article en
1 citations

Abstract

Influenza viruses continue to cause a substantial global disease burden. Despite influenza vaccination, some individuals succumb to life-threatening influenza or death. Yet our understanding of immune features elicited by vaccination and influenza A and B virus (IAV, IBV) infection is limited. To define molecular signatures of influenza-specific B-cells, we performed scRNA-sequencing of influenza-specific B-cells in vaccinees and hospitalized IAV/IBV-infected patients using HA-probes. We observed increased interferon-stimulated gene signatures (IF44L, IFITM1 and XAF1), in total B-cells from IBV-patients, but not at 1-month following patients' recovery or in IAV-patients or vaccinees. Phenotypic differentiation and isotype class-switching of HA-specific B-cells were observed following vaccination, with clonal sharing between memory and atypical B-cell phenotypes. In-vitro influenza virus infection experiments showed IBVs having higher infectivity of human PBMCs, including B-cells, and reduced B-cell proliferation compared to IAV, potentially associated with antiproliferative effect of IFITM1. We provide key insights into B-cell immunity towards IBV and IAV infections and vaccination, which will inform rational vaccine design and therapeutic strategies aimed at eliciting robust HA-specific B-cell responses, while minimizing adverse effects caused by natural infection.

EMBO Molecular Medicine
CSL (United Kingdom) (GB), St. Jude Children's Research Hospital (US), Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA), Infectious Disease Research Institute (US), The University of Melbourne (AU), Walter and Eliza Hall Institute of Medical Research (AU), Peter MacCallum Cancer Centre (AU), The Alfred Hospital (AU), Monash Alfred Psychiatry Research centre (AU), Peter Doherty Institute (AU), Monash Health (AU), HKU-Pasteur Research Pole (HK), Austin Health (AU), Monash University (AU), University of Hong Kong (HK)
National Institutes of Health, Medical Research Council, National Health and Medical Research Council, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 0%
Influenza Virus Research Studies
31.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.